Cite
MLA Citation
Rory Bennett et al.. “The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience.” Leukemia & lymphoma, vol. 63, no. 7, 2022, pp. 1738–1741. http://access.bl.uk/ark:/81055/vdc_100159165895.0x00002b